OBJECTIVE: Complex regional pain syndrome type I (CRPS-I) is a severely disabling pain syndrome for which no definite treatment has been established. The aim of this multi-centre, randomized, double-blind placebo-controlled trial was to test the efficacy of the amino-bisphosphonate neridronate in patients with CRP-I. METHODS: Eighty-two patients with CRP-I at either hand or foot were randomly assigned to i.v. infusion of 100 mg neridronate given four times over 10 days or placebo. After 50 days the former placebo patients were given open label the same regimen of neridronate. RESULTS: Within the first 20 days, visual analogue scale (VAS) score decreased significantly more in the neridronate group. In the following 20 days, VAS remained u...
AbstractComplex regional pain syndrome (CRPS) is a potentially debilitating chronic pain syndrome wi...
Complex regional pain syndrome (CRPS) is a descriptive term for a complex of symptoms and signs typi...
Treatment of complex regional pain syndrome type I (CRPS-I) is subject to discussion. The purpose of...
Background: Complex regional pain syndrome type-1 (CRPS-1) is a severely disabling painful disease c...
Background: No data on the permanent and curative effect of bisphosphonate treatment in patients wit...
Complex Regional Pain Syndrome (CRPS) is a multifactorial and disabling disorder with complex etiolo...
Although multiple treatments have been advocated for complex regional pain syndrome (CRPS), the leve...
ObjectiveGuidelines for complex regional pain syndrome (CRPS) 1 advocate several substance classes t...
Complex Regional Pain Syndrome (CRPS) is still a debated topic although the most recent advances in ...
OBJECTIVE Guidelines for complex regional pain syndrome (CRPS) 1 advocate several substance classes...
OBJECTIVE: To evaluate the effects of the antiresorptive agent alendronate at a daily oral dose of 4...
Background: Treatment of complex regional pain syndrome type I (CRPS-I) is subject to discussion. Th...
Complex regional pain syndrome type I (CRPS-I)includes different conditions characterized by regiona...
Davide Gatti, Maurizio Rossini, Ombretta Viapiana, Luca Idolazzi, Silvano AdamiRheumatology Unit, De...
Neridronate is an aminobisphosphonate, licensed in Italy for the treatment of osteogenesis imperfect...
AbstractComplex regional pain syndrome (CRPS) is a potentially debilitating chronic pain syndrome wi...
Complex regional pain syndrome (CRPS) is a descriptive term for a complex of symptoms and signs typi...
Treatment of complex regional pain syndrome type I (CRPS-I) is subject to discussion. The purpose of...
Background: Complex regional pain syndrome type-1 (CRPS-1) is a severely disabling painful disease c...
Background: No data on the permanent and curative effect of bisphosphonate treatment in patients wit...
Complex Regional Pain Syndrome (CRPS) is a multifactorial and disabling disorder with complex etiolo...
Although multiple treatments have been advocated for complex regional pain syndrome (CRPS), the leve...
ObjectiveGuidelines for complex regional pain syndrome (CRPS) 1 advocate several substance classes t...
Complex Regional Pain Syndrome (CRPS) is still a debated topic although the most recent advances in ...
OBJECTIVE Guidelines for complex regional pain syndrome (CRPS) 1 advocate several substance classes...
OBJECTIVE: To evaluate the effects of the antiresorptive agent alendronate at a daily oral dose of 4...
Background: Treatment of complex regional pain syndrome type I (CRPS-I) is subject to discussion. Th...
Complex regional pain syndrome type I (CRPS-I)includes different conditions characterized by regiona...
Davide Gatti, Maurizio Rossini, Ombretta Viapiana, Luca Idolazzi, Silvano AdamiRheumatology Unit, De...
Neridronate is an aminobisphosphonate, licensed in Italy for the treatment of osteogenesis imperfect...
AbstractComplex regional pain syndrome (CRPS) is a potentially debilitating chronic pain syndrome wi...
Complex regional pain syndrome (CRPS) is a descriptive term for a complex of symptoms and signs typi...
Treatment of complex regional pain syndrome type I (CRPS-I) is subject to discussion. The purpose of...